These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8104720)
1. [Study of c-erbB-2 expression in breast neoplasms]. Ye F Zhonghua Bing Li Xue Za Zhi; 1993 Apr; 22(2):104-6. PubMed ID: 8104720 [TBL] [Abstract][Full Text] [Related]
2. [Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies]. Edorh A; Parache RM; Migeon C; N'Sossani B; Rihn B Pathol Biol (Paris); 1995 Sep; 43(7):584-9. PubMed ID: 8570262 [TBL] [Abstract][Full Text] [Related]
4. C-erbB-2 oncogene protein in in situ and invasive lobular breast neoplasia. Porter PL; Garcia R; Moe R; Corwin DJ; Gown AM Cancer; 1991 Jul; 68(2):331-4. PubMed ID: 1676930 [TBL] [Abstract][Full Text] [Related]
5. NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue. Corbett IP; Henry JA; Angus B; Watchorn CJ; Wilkinson L; Hennessy C; Gullick WJ; Tuzi NL; May FE; Westley BR J Pathol; 1990 May; 161(1):15-25. PubMed ID: 1973458 [TBL] [Abstract][Full Text] [Related]
6. Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease. Meissner K; Rivière A; Haupt G; Löning T Am J Pathol; 1990 Dec; 137(6):1305-9. PubMed ID: 1701961 [TBL] [Abstract][Full Text] [Related]
7. Molecular markers in Paget disease of the breast. Fu W; Lobocki CA; Silberberg BK; Chelladurai M; Young SC J Surg Oncol; 2001 Jul; 77(3):171-8. PubMed ID: 11455553 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study on the expression of c-erbB-2 oncoprotein in breast cancer. Horiguchi J; Iino Y; Takei H; Yokoe T; Ishida T; Morishita Y Oncology; 1994; 51(1):47-51. PubMed ID: 7903441 [TBL] [Abstract][Full Text] [Related]
9. The role of p53 and Ki67 in Paget's disease of the vulva and the breast. Ellis PE; Fong LF; Rolfe KJ; Crow JC; Reid WM; Davidson T; MacLean AB; Perrett CW Gynecol Oncol; 2002 Aug; 86(2):150-6. PubMed ID: 12144821 [TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer. Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782 [TBL] [Abstract][Full Text] [Related]
11. Paget's disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1. Mrhalova M; Kodet R Neoplasma; 2003; 50(6):396-402. PubMed ID: 14689059 [TBL] [Abstract][Full Text] [Related]
12. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features. Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Lodato RF; Maguire HC; Greene MI; Weiner DB; LiVolsi VA Mod Pathol; 1990 Jul; 3(4):449-54. PubMed ID: 2170971 [TBL] [Abstract][Full Text] [Related]
14. 99m Tc MIBI prone scintimammography in breast Paget's disease: a case report. Mezi S; Scopinaro F; Marzullo A; Sallusti E; David V; Ierardi M; Tiberio NS; Modesti M Oncol Rep; 1999; 6(1):45-8. PubMed ID: 9864399 [TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas. Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE Anticancer Res; 1997; 17(2B):1319-30. PubMed ID: 9137492 [TBL] [Abstract][Full Text] [Related]
16. c-erbB-2 expression in benign and malignant breast disease. Gusterson BA; Machin LG; Gullick WJ; Gibbs NM; Powles TJ; Elliott C; Ashley S; Monaghan P; Harrison S Br J Cancer; 1988 Oct; 58(4):453-7. PubMed ID: 2849975 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of c-erbB-2 amplification in breast carcinoma by differential polymerase chain reaction. Gramlich TL; Cohen C; Fritsch C; DeRose PB; Gansler T Am J Clin Pathol; 1994 Apr; 101(4):493-9. PubMed ID: 7909190 [TBL] [Abstract][Full Text] [Related]
18. c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma. Collier JD; Guo K; Mathew J; May FE; Bennett MK; Corbett IP; Bassendine MF; Burt AD J Hepatol; 1992 Mar; 14(2-3):377-80. PubMed ID: 1380026 [TBL] [Abstract][Full Text] [Related]
19. Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significance. Blin N; Kardaś I; Welter C; Ryś J; Niezabitowski A; Limon J; Seitz G Oncology; 1993; 50(6):408-11. PubMed ID: 7901823 [TBL] [Abstract][Full Text] [Related]
20. The relationship between flow-cytometric and immunohistochemically detected c-erbB-2 expression, grade and DNA ploidy in breast cancer. Brotherick I; Shenton BK; Cowan WK; Angus B; Horne CH; Higgs MJ; Lennard TW Cancer Immunol Immunother; 1995 Sep; 41(3):137-45. PubMed ID: 7553681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]